I
n recent decades, hypertension and prehypertension-conditions formerly confined largely to adults-have pervaded pediatric populations. Although data from the National Health and Nutrition Examination Survey (NHANES) 2011 to 2012 indicate that the prevalence of hypertension (≥95th percentile age-, sex-, and height-specific systolic or diastolic blood pressure [BP] 1 ) and prehypertension (90-<95 percentile 1 ) is leveling off 2 following increases during earlier survey periods, 3 these conditions still affect >1 in 10 youth in the United States. Considering that BP tracks from childhood into adulthood 4 and that raised BP in early life is an independent risk factor for future cardiovascular disease, 5 it is important to identify early life risk factors for elevated BP in children to inform timely strategies for cardiovascular disease prevention.
Pre-and postnatal growth may influence future BP. Larger size at birth, typically assessed by birth weight, 6 and faster weight gain during the first 2 postnatal years are consistently associated with obesity in childhood and adulthood, 6, 7 with some 8, 9 investigations also showing relationships with higher BP. Yet, several issues remain to be clarified. First, although some studies suggest that weight gain patterns in early infancy-for example, during the first 6 postnatal months 9, 10 -are particularly important to future BP, 2 recent investigations 11, 12 observed that weight gain during childhood was a stronger predictor of future BP than were gains in infancy, highlighting the need for additional research to reconcile mixed findings. Second, the role of adiposity gain as compared with linear growth has received little attention, but are each important to be considered separately because weight contains fat mass and height, both of which are positively associated with BP in children. 13, 14 Third, the extent to which birth size modifies the associations of postnatal growth Abstract-In recent years, the prevalence of hypertension and prehypertension increased markedly among children and adolescents, highlighting the importance of identifying determinants of elevated blood pressure early in life. Low birth weight and rapid early childhood weight gain are associated with higher future blood pressure. However, few studies have examined the timing of postnatal weight gain in relation to later blood pressure, and little is known regarding the contribution of linear growth. We studied 957 participants in Project Viva, an ongoing US prebirth cohort. We examined the relations of gains in body mass index z-score and length/height z-score during 4 early life age intervals (birth to 6 months, 6 months to 1 year, 1 to 2 years, and 2 to 3 years) with blood pressure during mid-childhood (6-10 years) and evaluated whether these relations differed by birth size. After accounting for confounders, each additional z-score gain in body mass index during birth to 6 months and 2 to 3 years was associated with 0.81 (0.15, 1.46) and 1.61 (0.33, 2.89) mm Hg higher systolic blood pressure, respectively. Length/height gain was unrelated to mid-childhood blood pressure, and there was no evidence of effect modification by birth size for body mass index or length/height z-score gain. Our findings suggest that more rapid gain in body mass index during the first 6 postnatal months and in the preschool years may lead to higher systolic blood pressure in mid-childhood, regardless of size at birth. Strategies to reduce accrual of excess adiposity during early life may reduce mid-childhood blood pressure, which may also impact adult blood pressure and cardiovascular health. with future BP remains unclear. We previously found that infants who were thinner at birth were more susceptible to the adverse effects of rapid gain in weight-for-length during the first 6 postnatal months on BP at age 3 years. 9 Whether this finding persists into mid-childhood when BP is more highly correlated with adult BP 4 is not known. Finally, some studies observed an association between early weight gain and future BP only after adjusting for current body size (eg, weight status), 15, 16 which has raised concerns that the associations are a statistical artifact rather than a true causal relationship. 17 In this study, we investigated the associations of gain in body mass index (BMI) and linear growth during 4 early childhood age intervals, birth to 6 months, 6 months to 1 year, 1 to 2 years, and 2 to 3 years, with BP during mid-childhood, and assessed whether these relationships differed by birth size.
Methods

Study Population
We studied participants in Project Viva, an ongoing Boston-area prebirth cohort. Details on recruitment and study design have been published. 18 Of the 2128 live singleton births, 1708 mother-child pairs were eligible for the mid-childhood visit, of whom 65% (n=1116) attended an in-person visit at age 6 to 10 years (median 7.7). For this analysis, we further excluded children whose mothers had type 1 or 2 diabetes mellitus (n=16) and those with gestation length <34 weeks (n=45) because we were interested in patterns of growth among healthy, term infants of mothers without preexisting metabolic complications. After excluding an additional 159 participants with no data on birth size (birth weight-for-gestational-age z-score), early growth (BMI or length/height z-score change during at least one of the age intervals), or BP in mid-childhood, the final sample included 957 participants. Not all participants contributed to BMI-for-age z-score (BMIZ) and height-for-age z-score (HAZ) change during all age intervals (n=321 with BMIZ and HAZ data for all 4 time frames), but the subsamples were similar with respect to sociodemographic characteristics, as well as the exposures and outcomes of interest (Table S1 in the online-only Data Supplement). The 957 children in this study did not differ from the 159 participants who attended the mid-childhood visit but were not included in terms of household income; father's BMI; or maternal prepregnancy BMI, parity, or education. However, compared with children excluded from the analyses, the sample included a lower proportion of Black children (15.8% versus 24.4%), higher proportion of mothers who smoked before pregnancy (20.3% versus 12.0%), and lower proportion who smoked during pregnancy (8.9% versus 15.8%). All mothers provided written informed consent at recruitment and at outcome assessment. All children provided verbal assent at the mid-childhood visit. The institutional review board of Harvard Pilgrim Healthcare approved all study protocols.
Exposures
Birth Size
Medical records provided information on perinatal characteristics, including the child's sex, birth weight, delivery method, and delivery date. We calculated gestational age at birth from the date of the last menstrual period or from a second trimester ultrasound if the estimated delivery date differed by >10 days. We determined sex-specific birth weight-for-gestational-age z-scores and percentiles using US reference data. 19 We defined small-for-gestational age as <10th percentile and large-for-gestational age as ≥90th percentile.
BMIZ and Length/Height-for-Age z-Score Change
We obtained data on weight and length/height from medical records and research measures. Weight at birth, 1 year, and 2 years were abstracted from medical records. Weight at 6 months and 3 years was assessed at research visits, where research assistants weighed participants to the nearest 0.1 kg using an electronic scale (Tanita, Inc, Arlington Heights, IL). For length at birth and 6 months, we used the recumbent length board technique. 20 Length at 1 and 2 years was abstracted from clinical records. Because the pediatric clinics used the paper-and-pencil method to measure length, we applied a corrective algorithm to the clinical lengths to account for the systematic overestimation. 20 At the 3 year research visit, research assistants measured standing height to the nearest 0.1 cm with a calibrated stadiometer (Shorr Productions, Olney, MD).
We calculated BMI (kg/m 2 ) and determined age-and sex-specific z-scores for BMI and length/height using the World Health Organization (WHO) growth reference. 21, 22 We quantified change in BMIZ and HAZ during each age interval as the difference in values between the beginning and end of each time frame. Our previous study examined weight for length, which is highly correlated with BMIZ (Spearman's ρ: 0.81, 0.99, 0.98, and 0.99 at birth, 6 months, 1 year, and 2 years, respectively), which additionally incorporates age at measurement. Given this and the fact that BMIZ captures fat growth in mid-childhood, 23, 24 we decided to use BMIZ change as an indicator for weight gain for all age intervals. 
Outcome: Mid-Childhood BP
We measured BP using biannually calibrated automated oscillometric monitors (Dinamap Pro100, Tampa, Florida). Trained research assistants recorded BP on the child's upper arm ≤5 times at 1-minute intervals, while also taking note of the cuff size, child's position (sitting, semireclining, reclining, standing), activity level during measurement (still, moving, quiet, talking), time of day, and ambient temperature. Although the first measurement tended to be higher than the second through fifth measurements, we included all 5 in the analysis because it improves precision when quantifying between-person differences rather than absolute levels, particularly in children. 26 We used the average of the 5 measurements because the intraclass coefficient was high (0.74). We categorized children as prehypertensive if systolic BP (SBP) or diastolic BP (DBP) was ≥90th and <95th percentile and as hypertensive if SBP or DBP was ≥95th percentile according to the NHANES 1999 to 2000 BP reference for children and adolescents. 1 However, there were only 3 cases of prehypertension and 2 cases of hypertension in mid-childhood; thus, we present associations with continuous BP only.
Additional Participant Characteristics
Mothers reported on their age, race/ethnicity, education, parity, household income, smoking habits in pregnancy, prepregnancy weight, and paternal weight and height via interviews and questionnaires administered at enrollment. In postpartum questionnaires, women reported on breastfeeding duration. Medical records provided information on prenatal glucose tolerance. We calculated maternal prepregnancy BMI using self-reported prepregnancy weight and height and used standard adult classifications for weight status. 27 To identify women with hypertensive disorders of pregnancy, we reviewed outpatient charts for BP and urine protein results and created a 4-level variable with the categories normotensive, chronic hypertension, gestational hypertension, and preeclampsia as previously described. 28 At the mid-childhood visit, research assistants measured children's weight to the nearest 0.1 kg with an electronic scale and height to the nearest 0.1 cm with a calibrated stadiometer. We calculated age-and sex-specific height z-scores using the Centers for Disease Control 2 to 20 year growth reference. 29 
Data Analysis
We first examined bivariate associations of SBP and DBP across categories of sociodemographic and perinatal characteristics to identify potential confounders. We then examined the unadjusted associations of birth size using conventional categories (small-for-gestational age, appropriate-for-gestational age, large-for-gestational age) and continuously as birth weight-for-gestational age z-score, and BMIZ and HAZ change during each age interval with mid-childhood BP. We assessed BMIZ and HAZ change in quartiles to ensure linear associations before examining them as continuous variables.
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Next, we used multivariable linear regression models that accounted for maternal education, age, prepregnancy BMI, and smoking habits in pregnancy; birth weight-for-gestational-age z-score; and the child's age, sex, race/ethnicity to investigate associations of BMIZ and HAZ change during each age interval with BP in midchildhood. For the later growth periods, we also adjusted for growth during prior age intervals to account for the influence of previous growth on growth during the time frame of interest. Because correlations between BMIZ and HAZ change were moderately high for certain periods (Table S2) , we evaluated for multicollinearity using the variance inflation factor. Variance inflation factor for all models were <2.5, which is below the standard cut-off of 10 that indicates high multicollinearity. 30 We conducted a formal test for an interaction between BMIZ and HAZ change during each period with birth weight-for-gestational age z-score and sex, separately, and found no indication of effect modification by either variable (P interaction >0.05).
Because height is a strong determinant of BP during childhood 14 and because clinical assessments of pediatric BP are based on age-, sex-, and height-specific values, 1 we reran analyses with BP z-score as the outcome. In sensitivity analyses, we further adjusted for gestational diabetes mellitus, delivery method, breastfeeding, and paternal BMI; accounting for these characteristics did not change our findings. Because the age interval time frames were not of equal length, we assessed BMIZ and HAZ change as velocities. Using velocities yielded no change in the direction, magnitude, or precision of the results; therefore, we present results in terms of BMIZ and HAZ change for interpretability.
All analyses were performed with Statistical Analyses System software (v9.3; SAS Institute Inc, Cary, NC).
Results
Among the 957 participants, mean±SD birth weight-forgestational age z-score was 0.21±0.96 and birth weight was 3516±511 g. Children were 7.9±0.8 years old at the midchildhood visit, and average SBP and DBP were 94.4±8.8 mm Hg and 54.3±5.7 mm Hg, respectively.
In bivariate analyses, maternal age and parity were inversely related to offspring DBP in mid-childhood, whereas maternal prepregnancy BMI and smoking during pregnancy were associated with higher offspring SBP and DBP (Table 1) . We observed differences in mid-childhood BP with respect to race/ethnicity. Although black and white children had similar BP levels (P=0.32), hispanic children had 4.03 (95% confidence interval: 1.24, 6.81) mm Hg lower SBP than their white peers (P=0.005). Children whose mothers had chronic hypertension and gestational hypertension had 6.52 (1.74, 11.31) mm Hg and 2.61 (0.33, 4.90) mm Hg higher SBP, respectively, as compared with those of women with normal BP; similar but weaker associations were observed for DBP. Birth weight-forgestational age z-score was inversely associated with DBP, but not SBP (Table 1) .
In unadjusted analysis, children born large for gestational age had 1.23 (0.17, 2.28) mm Hg lower DBP in mid-childhood than those who had been appropriate-for-gestational age newborns; the inverse relation with DBP was also apparent when we examined birth size continuously (−0.45 [−0.83, −0.07] mm Hg per birth weight-for-gestational-age z-score; Table 2 ). Greater BMIZ gain from birth to 6 months was associated with higher SBP and DBP (Table 2 ). There were no consistent relations of HAZ change with mid-childhood BP.
After accounting for confounders and previous growth, BMIZ change from birth to 6 months and 2 to 3 years were each associated with higher mid-childhood SBP. The Table S3 ). The relation of BMIZ change from 6 months to 1 year with SBP was similar to that of birth to 6 months, but with wider confidence intervals (0.86 [−0.14, 1.85] mm Hg per z-score BMI gain). Associations with heightstandardized BP z-scores paralleled those of raw BP.
Discussion
In this study, each increment in BMI z-score gain during the first 6 postnatal months and 2 to 3 years of age corresponded with 0.7 and 1.5 mm Hg higher SBP, respectively, in midchildhood. In contrast to earlier studies, 15, 16 including one in Project Viva that examined BP at 3 to 5 years of age, 9 we found no evidence of an interaction between birth size and BMIZ or length/height gain.
Previous studies have emphasized the first months of life as a sensitive period for development of cardiovascular risk. 9, [31] [32] [33] In contrast, relatively little is known regarding the influence of adiposity accrual and linear growth during the toddler or preschool years. Our finding that BMIZ gain from 2 to 3 years had a larger influence on mid-childhood BP than did gains in infancy corroborates 2 recent investigations. In a study of 13 889 Belarusian participants of the Promotion of Breastfeeding Intervention Trial (PROBIT), Tilling et al reported that in comparison to weight gain from birth to 3 months and 3 months to 1 year, weight gain from 1 to 5 years was a stronger determinant of BP at 6.5 years after adjustment for confounders and previous growth. In another study of 12 962 UK children in the Avon Longitudinal Study of Parents and Children (ALSPAC), Jones et al 11 used conditional growth modeling, a strategy comparable to previous growth adjustment, to explore how gains in weight, weight-for-height, and height correspond with BP at 10 years during 2 time frames: birth to 17 months and 17 months to 10 years. Weight and weight-for-height gain during both periods predicted higher SBP, but a larger association was observed for 17 months to 10 years. 11 Our findings add to this evidence base, especially because we examined more granular and evenly spaced temporal windows. The fact that the relationship between BMI gain and future BP was most robust during the toddler/early preschool years is salient because this time frame coincides with biannual well-child visits at which healthcare providers monitor growth and make recommendations to parents for optimal child health. Our findings also support the need for obesity prevention and nutrition programs in preschool or childcare settings because they may be feasible and effective community-based strategies to prevent excess early weight gain on a larger scale. 34 We also found that BMIZ change during the birth to 6 month time frame, and to some extent from 6 months to 1 year, corresponded with higher mid-childhood SBP-albeit at half the magnitude of what we observed for the 2 to 3 year interval. This finding aligns with that of Ben-Schlomo et al, 10 who reported that faster weight gain from birth to 5 months and 1 year 9 months to 5 year were stronger predictors of adult SBP than were gains from 5 months to 1 year 9 months, with larger effect sizes during the 1 year 9 months to 5 year period (1.29 versus 1.44 mm Hg). 10 A potential reason for the null relation between 1 to 2 year BMIZ gain and mid-childhood BP in our study is that both weight and length/height measurements were derived from medical records, which may be less precise than research standard measures. For example, clinics used the paper-and-pencil method to measure length in infants, which leads to an overestimation of ≈1.3±1.5 cm as compared with the research standard recumbent length board technique. 20 Although we applied a length correction factor to account for this difference in technique, residual nonsystematic bias could still obscure associations.
Contrary to findings in ALSPAC that linear growth during infancy and childhood were positively associated with mid-childhood SBP, with effect sizes comparable to those for weight gain, 11 early life HAZ change was unrelated to midchildhood BP in our study. Given the positive relationship between age and BP in pre-and peri-pubertal children, 35 the discrepancy in findings could be related to the older age at BP assessment in ALSPAC children (≈10.5 years in ALSPAC versus ≈8 years in Project Viva).
There are a few biological mechanisms that could link early adiposity accrual with future BP. The first years of life represent a period of rapid growth and development; thus, environmental and genetic factors that affect accrual of adiposity and linear growth may also influence cardiovascular system ontogeny. For example, the ratio of elastin to collagen fibers in cardiac tissue, a determinant of arterial stiffness and thus propensity for high BP, is established before birth. 36 In this scenario, early life weight gain share an upstream cause with elevated BP, but is not a direct causal mechanisms. Another explanation relates to the fact that rapid postnatal and childhood weight gain is consistently associated with future obesity, 6 possibly through early programming and establishment of adipocyte quantity. 37 Higher adiposity 13 -in particular, greater central fat mass 38 -is a strong determinant of BP in both children and adults. Proposed mechanisms range from physical compression of the kidneys to endocrine effects of adipose tissue that cause dysregulation of hormones and cytokines involved in vascular function. 39 This investigation has several strengths, including some improvements on our previous study investigating relations of weight-for-length change from birth to 6 months with BP at 3 to 5 years. 9 First, we assessed age-standardized measures of adiposity, as well as length/height gain, during multiple early life age intervals. Second, although associations with early childhood BP are informative, mid-childhood may be more relevant time frame in light of stronger correlations between BP during this time frame and adult BP. 4 Additionally, as compared with findings from other contemporary cohorts, our results are more relevant to the current US population. For example, ALSPAC and PROBIT recruitment date in the earlyto -mid-1990s with 8.7% 40 and 5.5% 41 prevalence of obesity during mid-childhood, respectively, as compared with 12% in Project Viva. Considering 2012 estimates that 18% of US children 6 to 11 years of age are obese, 42 our results are more applicable to current populations in terms of prevalence of obesity and related metabolic sequelae.
This study has some limitations. First, results can be impeded by unmeasured confounding, although we accounted for key sociodemographic and perinatal characteristics. Second, as with all cohort studies, there may be attrition bias because participants who remained in the study through midchildhood follow-up tended to be older and white, with a AGA indicates appropriate-for-gestational age; BP, blood pressure; DBP, diastolic blood pressure;
LGA, large-for-gestational-age; SBP, systolic blood pressure; and SGA, small-for-gestational-age.
*Represents a test for linear trend with the exception of smoking habits in pregnancy, hypertensive disorders of pregnancy, and race/ethnicity (Wald test). †According to the WHO standard adult weight status classification. 27 ‡According to US natality reference data. larger proportion of mothers who are college graduates and nonsmokers with higher annual income. 18 Third, we have limited generalizability to lower socioeconomic populations and developing countries because Project Viva is a relatively welleducated population. It has also been suggested that compared with auscultation, oscillometric devices overestimate BP, leading to misclassification of prehypertension or hypertension. 43 Because NHANES uses the auscultatory method, standardization of BP of Project Viva participants using this reference may lead to systematic overestimation of z-scores. However, we analyzed BP as a continuous variable and expect the relative rank of individual BP to be preserved. Finally, because BP assessments in formal settings may induce the white coat effect, it is possible that BP measurements were higher than usual. However, we took 5 repeated measurements to overcome the possibility, and again, because were interested in continuous BP, interindividual differences were likely captured. Future studies might consider use of ambulatory BP monitoring, which is useful in evaluation of hypertension in children. 44 
Perspectives
An individual's BP relative to the population is established during the first decade of life, 4 emphasizing the importance of identifying early predisposing factors for raised BP. The size of associations we detected with respect to early weight gain LGA ( AGA indicates appropriate-for-gestational age; BMI, body mass index; BMIZ, BMI-for-age z-score; CI, confidence interval; DBP, diastolic blood pressure; HAZ, height-for-age z-score;
*Bolded estimate represent statistical significance at P<0.05. †BWZ: Sex-specific birth weight-for-gestational-age z-score according to US natality reference data. 19 ‡z-Scores were determined using the WHO growth reference. 21, 22 Values represent the difference in BMIZ or HAZ between the beginning and end of each time frame.
Figure.
Associations of body mass index (BMI)-for-age z-score (BMIZ) and heightfor-age z-score (HAZ) change during 4 age intervals with mid-childhood systolic blood pressure (SBP). Estimates are adjusted for maternal prepregnancy BMI, age, smoking habits in pregnancy, hypertensive disorders of pregnancy, and education; birth weight-for-gestational-age z-score; and child's age at mid-childhood visit, sex, race/ethnicity, and BMIZ or HAZ change during all previous age intervals.
by guest on August 30, 2017 http://hyper.ahajournals.org/ Downloaded from (differences of 0.7-1.4 mm Hg SBP), while relatively small, may be relevant from a population prevention perspective 45 considering that a 1 mm Hg increment in childhood SBP predicted elevations in a cluster of metabolic risk factors in young adulthood, including SBP, cholesterol, triglycerides, and fasting glucose in the Bogalusa Heart Study. 46 Our findings suggest that a focus on strategies to reduce development of excess adiposity during the immediate postnatal period and in the preschool years may have lifelong benefits for cardiovascular health.
